A trial has been launched in Germany on a vaccine designed to prevent the spread of the coronavirus, which affects about 3.2 million people worldwide and kills 227,000 people.
The first vaccine to be developed by the UK was launched on April 23 last week before Germany.
Before the United Kingdom, two vaccines manufactured by various American companies were tested on humans and now a trial of the vaccine has also been started by Germany.
In all, as of April 30, only four vaccines have been tested on humans worldwide, while the United States has begun testing the TB vaccine on corona patients.
In addition, drugs used in various diseases are being tested in many countries around the world, including the United States, the United Kingdom, Germany, India, Pakistan, Australia, and China, but only 4 vaccines developed specifically for corona. The trial of humans has begun
According to the Arab broadcaster Al Jazeera, the vaccine, developed by the German company Biotech and the multinational pharmaceutical company Pfizer, was tested on humans this week and by April 30, 12 doses of the vaccine had been given to volunteers.
The vaccine, named BNT162, will be tested on a total of 200 volunteers between the ages of 18 and 55.
Pfizer, a multinational pharmaceutical company that develops the vaccine, has applied to start testing the same vaccine in the United States, and it is hoped that the vaccine will be allowed to be tested in the United States.
The vaccine is expected to be available on the market within the next one to one-and-a-half years if successful testing of the BNT-162 injection on humans begins.